raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:324

Fabry disease

Synonyms: Alpha-galactosidase A deficiency · Anderson-Fabry disease · FD

Type
Disease
Group
Disorder
Inheritance
X-linked dominant, X-linked recessive
Age of onset
Adolescent, Adult, Childhood
Status
active

A rare genetic, multisystemic lysosomal disease characterized by specific cutaneous (angiokeratoma), neurological (pain), renal (proteinuria, chronic kidney failure), cardiovascular (cardiomyopathy, arrhythmia), cochleo-vestibular and cerebrovascular manifestations (transient ischemic attacks, strokes). The phenotypic expression depends on age of onset and, in females, the level of X-inactivation.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enFabry diseaseAlpha-galactosidase A deficiency · Anderson-Fabry disease · FD
frMaladie de FabryDéficit en alpha-galactosidase A · FD · Maladie d'Anderson-Fabry · Sphingolipidose héréditaire de Fabry · Thésaurismose lipoïdique héréditaire
deFabry-SyndromAlpha-Galaktosidase A-Mangel · Anderson-Fabry-Krankheit · FD · Fabry-Krankheit
esEnfermedad de FabryDeficiencia de alfa-galactosidasa A · Enfermedad de Anderson-Fabry
itMalattia di FabryDeficit di alfa-galattosidasi A · FD · Malattia di Anderson-Fabry
nlZiekte van FabryAlfa-galactosidase A-deficiëntie · FD · Ziekte van Anderson-Fabry
ptDoença FabryDeficiência de alfa-galactosidase A · Doença Anderson-Fabry · FD
plChoroba Fabry'egoChoroba Andersona i Fabry'ego · FD · Niedobór alfa-galaktozydazy A · Rogowiec naczyniowy rozlany · Rozsiane zmiany o charakterze angiokeratoma
csFabryho nemocDeficit alfa-galaktosidázy A · Andersonova-Fabryho nemoc · Angiokeratoma corporis diffusum · Anderson-Fabryho nemoc
ukХвороба ФабріДефіцит альфа-галактозидази А · Хвороба Андерсона-Фабрі · Ангіокератома дифузна (Angiokeratoma corporis diffusum) · Дифузна ангіокератома · FD
zh法布里病α-半乳糖苷酶A缺乏症
trFabry hastalığıFD · Yaygın anjiyokeratom · Anderson-Fabry hastalığı · Anjiyokeratoma korporis diffusum · Alfa-galaktosidaz A eksikliği

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM301500Evalidated
ICD-10E75.2NTBTinclusionvalidated
ICD-115C56.01Especificvalidated
MONDO0010526Evalidated
MeSHD000795Evalidated
UMLSC0002986Evalidated
GARD6400Evalidated
MedDRA10016016Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (12):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
GLADisease-causing germline mutation(s) inAssessedHGNC:4296ENSG00000102393300644Xq22.1galactosidase alpha20301469[PMID]
5

Prevalence and incidence

11 records
TypeClassValueAreaQualificationValidationSource
Prevalence at birth1-9 / 1 000 0006.66 / 100 000WorldwideValue and classValidatedORPHANET
Prevalence at birth1-9 / 1 000 0006.96 / 100 000AustraliaValue and classValidated35024668[PMID]
Prevalence at birth1-9 / 1 000 0000.21 / 100 000NetherlandsValue and classValidated10480370[PMID]
Prevalence at birth1-9 / 1 000 0000.12 / 100 000PortugalValue and classValidated14685153[PMID]
Prevalence at birth1-9 / 1 000 0000.52 / 100 000Czech RepublicValue and classValidated20490927[PMID]
Prevalence at birth<1 / 1 000 0000.015 / 100 000TurkeyValue and classValidated15275696[PMID]
Point prevalence1-9 / 1 000 0000.15 / 100 000United KingdomValue and classValidated11732485[PMID]
Prevalence at birth1-9 / 1 000 0000.25 / 100 000JapanValue and classValidated22790789[PMID]
Point prevalence1-5 / 10 000—EuropeClass onlyNot yet validatedORPHANET
Prevalence at birth1-9 / 100 0001.11 / 100 000SwedenValue and classValidated25274184[PMID]
Point prevalence1-9 / 1 000 0000.118 / 100 000ChinaValue and classValidated34103049[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

76 annotations · validated 2023-08-25
HPOTerm (as annotated by Orphanet)Diagnostic
Very frequent (99-80%)
HP:0002027Abdominal pain
HP:0004343Abnormal glycosphingolipid metabolism
HP:0001903Anemia
HP:0001014Angiokeratoma
HP:0002829Arthralgia
HP:0001369Arthritis
HP:0001635Congestive heart failure
HP:0000524Conjunctival telangiectasia
HP:0001131Corneal dystrophy
HP:0007957Corneal opacity
HP:0034864Decreased alpha-galactosidase A activity
HP:0033595Elevated circulating globotriaosylceramide concentration
HP:0012378Fatigue
HP:0000365Hearing impairment
HP:0000790Hematuria
HP:0000962Hyperkeratosis
HP:0000966Hypohidrosis
HP:0002024Malabsorption
HP:0100579Mucosal telangiectasiae
HP:0003326Myalgia
HP:0000100Nephrotic syndrome
HP:0000083Renal insufficiency
HP:0001482Subcutaneous nodule
HP:0100585Telangiectasia of the skin
HP:0002326Transient ischemic attack
Frequent (79-30%)
HP:0001646Abnormal aortic valve morphology
HP:0003119Abnormal circulating lipid concentration
HP:0000091Abnormal renal tubule morphology
HP:0031006Acroparesthesia
HP:0002039Anorexia
HP:0001678Atrioventricular block
HP:0000708Atypical behavior
HP:0011710Bundle branch block
HP:0000518Cataract
HP:0012532Chronic pain
HP:0000280Coarse facial features
HP:0100543Cognitive impairment
HP:0500008Cornea verticillata
HP:0000823Delayed puberty
HP:0002097Emphysema
HP:0003546Exercise intolerance
HP:0002046Heat intolerance
HP:0003077Hyperlipidemia
HP:0001653Mitral regurgitation
HP:0002017Nausea and vomiting
HP:0000112Nephropathy
HP:0000648Optic atrophy
HP:0000093Proteinuria
HP:0004322Short stature
HP:0000179Thick lower lip vermilion
HP:0000360Tinnitus
Occasional (29-5%)
HP:0001637Abnormal myocardium morphology
HP:0002823Abnormality of femur morphology
HP:0004306Abnormality of the endocardium
HP:0002571Achalasia
HP:0001681Angina pectoris
HP:0000739Anxiety
HP:0011675Arrhythmia
HP:0006510Chronic pulmonary obstruction
HP:0000716Depression
HP:0002376Developmental regression
HP:0000873Diabetes insipidus
HP:0002094Dyspnea
HP:0001945Fever
HP:0100820Glomerulopathy
HP:0000822Hypertension
HP:0001639Hypertrophic cardiomyopathy
HP:0001712Left ventricular hypertrophy
HP:0001004Lymphedema
HP:0004349Reduced bone mineral density
HP:0002093Respiratory insufficiency
HP:0001250Seizure
HP:0000407Sensorineural hearing impairment
HP:0001297Stroke
HP:0002321Vertigo
Very rare (<4-1%)
HP:0000975Hyperhidrosis

Run the differential on the 12 obligate / very frequent terms

Annotation source: 20301469[PMID]

7

Sources for this card